調査レポート | • レポートコード：QYR2104Z5057 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、治療用RNAiのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（siRNA、miRNA、shRNA）、用途別市場規模（がん、循環器、HBV、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・治療用RNAiの市場動向 ・企業の競争状況、市場シェア ・治療用RNAiの種類別市場規模（siRNA、miRNA、shRNA） ・治療用RNAiの用途別市場規模（がん、循環器、HBV、その他） ・治療用RNAiの北米市場規模2016-2027（アメリカ、カナダ） ・治療用RNAiのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・治療用RNAiのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・治療用RNAiの中南米市場規模2016-2027（メキシコ、ブラジル） ・治療用RNAiの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Alnylam Pharmaceuticals、Arbutus Biopharma (Tekmira)、Arrowhead、Dicerna Pharmaceuticals、Mirna Therapeutics、Quark Pharmaceuticals、RXi Pharmaceuticals、Silence Therapeutics、Benitec Biopharma、miRagen Therapeutics、Sylentis、Gradalis、Sirnaomics、Silenseed） ・結論 |
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
Market Analysis and Insights: Global RNAi for Therapeutic Market
The global RNAi for Therapeutic market size is projected to reach US$ 6616.2 million by 2026, from US$ 1521.7 million in 2019, at a CAGR of 23.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNAi for Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNAi for Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNAi for Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNAi for Therapeutic market.
Global RNAi for Therapeutic Scope and Market Size
RNAi for Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNAi for Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
siRNA
miRNA
shRNA
Segment by Application
Cancer
Cardiovascular
HBV
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
Dicerna Pharmaceuticals
Mirna Therapeutics
Gradalis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi for Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 siRNA
1.2.3 miRNA
1.2.4 shRNA
1.3 Market by Application
1.3.1 Global RNAi for Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global RNAi for Therapeutic Market Perspective (2016-2027)
2.2 RNAi for Therapeutic Growth Trends by Regions
2.2.1 RNAi for Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNAi for Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 RNAi for Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 RNAi for Therapeutic Industry Dynamic
2.3.1 RNAi for Therapeutic Market Trends
2.3.2 RNAi for Therapeutic Market Drivers
2.3.3 RNAi for Therapeutic Market Challenges
2.3.4 RNAi for Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi for Therapeutic Players by Revenue
3.1.1 Global Top RNAi for Therapeutic Players by Revenue (2016-2021)
3.1.2 Global RNAi for Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNAi for Therapeutic Revenue
3.4 Global RNAi for Therapeutic Market Concentration Ratio
3.4.1 Global RNAi for Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi for Therapeutic Revenue in 2020
3.5 RNAi for Therapeutic Key Players Head office and Area Served
3.6 Key Players RNAi for Therapeutic Product Solution and Service
3.7 Date of Enter into RNAi for Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi for Therapeutic Breakdown Data by Type
4.1 Global RNAi for Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global RNAi for Therapeutic Forecasted Market Size by Type (2022-2027)
5 RNAi for Therapeutic Breakdown Data by Application
5.1 Global RNAi for Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global RNAi for Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America RNAi for Therapeutic Market Size (2016-2027)
6.2 North America RNAi for Therapeutic Market Size by Type
6.2.1 North America RNAi for Therapeutic Market Size by Type (2016-2021)
6.2.2 North America RNAi for Therapeutic Market Size by Type (2022-2027)
6.2.3 North America RNAi for Therapeutic Market Size by Type (2016-2027)
6.3 North America RNAi for Therapeutic Market Size by Application
6.3.1 North America RNAi for Therapeutic Market Size by Application (2016-2021)
6.3.2 North America RNAi for Therapeutic Market Size by Application (2022-2027)
6.3.3 North America RNAi for Therapeutic Market Size by Application (2016-2027)
6.4 North America RNAi for Therapeutic Market Size by Country
6.4.1 North America RNAi for Therapeutic Market Size by Country (2016-2021)
6.4.2 North America RNAi for Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe RNAi for Therapeutic Market Size (2016-2027)
7.2 Europe RNAi for Therapeutic Market Size by Type
7.2.1 Europe RNAi for Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe RNAi for Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe RNAi for Therapeutic Market Size by Type (2016-2027)
7.3 Europe RNAi for Therapeutic Market Size by Application
7.3.1 Europe RNAi for Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe RNAi for Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe RNAi for Therapeutic Market Size by Application (2016-2027)
7.4 Europe RNAi for Therapeutic Market Size by Country
7.4.1 Europe RNAi for Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe RNAi for Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific RNAi for Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific RNAi for Therapeutic Market Size by Type
8.2.1 Asia-Pacific RNAi for Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNAi for Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNAi for Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific RNAi for Therapeutic Market Size by Application
8.3.1 Asia-Pacific RNAi for Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNAi for Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNAi for Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific RNAi for Therapeutic Market Size by Region
8.4.1 Asia-Pacific RNAi for Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNAi for Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America RNAi for Therapeutic Market Size (2016-2027)
9.2 Latin America RNAi for Therapeutic Market Size by Type
9.2.1 Latin America RNAi for Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America RNAi for Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America RNAi for Therapeutic Market Size by Type (2016-2027)
9.3 Latin America RNAi for Therapeutic Market Size by Application
9.3.1 Latin America RNAi for Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America RNAi for Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America RNAi for Therapeutic Market Size by Application (2016-2027)
9.4 Latin America RNAi for Therapeutic Market Size by Country
9.4.1 Latin America RNAi for Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America RNAi for Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi for Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
10.2.1 Middle East & Africa RNAi for Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNAi for Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNAi for Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
10.3.1 Middle East & Africa RNAi for Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNAi for Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNAi for Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa RNAi for Therapeutic Market Size by Country
10.4.1 Middle East & Africa RNAi for Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNAi for Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Details
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Arbutus Biopharma (Tekmira)
11.2.1 Arbutus Biopharma (Tekmira) Company Details
11.2.2 Arbutus Biopharma (Tekmira) Business Overview
11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Introduction
11.2.4 Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2016-2021)
11.2.5 Arbutus Biopharma (Tekmira) Recent Development
11.3 Arrowhead
11.3.1 Arrowhead Company Details
11.3.2 Arrowhead Business Overview
11.3.3 Arrowhead RNAi for Therapeutic Introduction
11.3.4 Arrowhead Revenue in RNAi for Therapeutic Business (2016-2021)
11.3.5 Arrowhead Recent Development
11.4 Dicerna Pharmaceuticals
11.4.1 Dicerna Pharmaceuticals Company Details
11.4.2 Dicerna Pharmaceuticals Business Overview
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Introduction
11.4.4 Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021)
11.4.5 Dicerna Pharmaceuticals Recent Development
11.5 Mirna Therapeutics
11.5.1 Mirna Therapeutics Company Details
11.5.2 Mirna Therapeutics Business Overview
11.5.3 Mirna Therapeutics RNAi for Therapeutic Introduction
11.5.4 Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021)
11.5.5 Mirna Therapeutics Recent Development
11.6 Quark Pharmaceuticals
11.6.1 Quark Pharmaceuticals Company Details
11.6.2 Quark Pharmaceuticals Business Overview
11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Introduction
11.6.4 Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021)
11.6.5 Quark Pharmaceuticals Recent Development
11.7 RXi Pharmaceuticals
11.7.1 RXi Pharmaceuticals Company Details
11.7.2 RXi Pharmaceuticals Business Overview
11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Introduction
11.7.4 RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021)
11.7.5 RXi Pharmaceuticals Recent Development
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Details
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics RNAi for Therapeutic Introduction
11.8.4 Silence Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021)
11.8.5 Silence Therapeutics Recent Development
11.9 Benitec Biopharma
11.9.1 Benitec Biopharma Company Details
11.9.2 Benitec Biopharma Business Overview
11.9.3 Benitec Biopharma RNAi for Therapeutic Introduction
11.9.4 Benitec Biopharma Revenue in RNAi for Therapeutic Business (2016-2021)
11.9.5 Benitec Biopharma Recent Development
11.10 miRagen Therapeutics
11.10.1 miRagen Therapeutics Company Details
11.10.2 miRagen Therapeutics Business Overview
11.10.3 miRagen Therapeutics RNAi for Therapeutic Introduction
11.10.4 miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021)
11.10.5 miRagen Therapeutics Recent Development
11.11 Sylentis
11.11.1 Sylentis Company Details
11.11.2 Sylentis Business Overview
11.11.3 Sylentis RNAi for Therapeutic Introduction
11.11.4 Sylentis Revenue in RNAi for Therapeutic Business (2016-2021)
11.11.5 Sylentis Recent Development
11.12 Gradalis
11.12.1 Gradalis Company Details
11.12.2 Gradalis Business Overview
11.12.3 Gradalis RNAi for Therapeutic Introduction
11.12.4 Gradalis Revenue in RNAi for Therapeutic Business (2016-2021)
11.12.5 Gradalis Recent Development
11.13 Sirnaomics
11.13.1 Sirnaomics Company Details
11.13.2 Sirnaomics Business Overview
11.13.3 Sirnaomics RNAi for Therapeutic Introduction
11.13.4 Sirnaomics Revenue in RNAi for Therapeutic Business (2016-2021)
11.13.5 Sirnaomics Recent Development
11.14 Silenseed
11.14.1 Silenseed Company Details
11.14.2 Silenseed Business Overview
11.14.3 Silenseed RNAi for Therapeutic Introduction
11.14.4 Silenseed Revenue in RNAi for Therapeutic Business (2016-2021)
11.14.5 Silenseed Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global RNAi for Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of siRNA
Table 3. Key Players of miRNA
Table 4. Key Players of shRNA
Table 5. Global RNAi for Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global RNAi for Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global RNAi for Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global RNAi for Therapeutic Market Share by Regions (2016-2021)
Table 9. Global RNAi for Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global RNAi for Therapeutic Market Share by Regions (2022-2027)
Table 11. RNAi for Therapeutic Market Trends
Table 12. RNAi for Therapeutic Market Drivers
Table 13. RNAi for Therapeutic Market Challenges
Table 14. RNAi for Therapeutic Market Restraints
Table 15. Global RNAi for Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global RNAi for Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top RNAi for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2020)
Table 18. Ranking of Global Top RNAi for Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by RNAi for Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players RNAi for Therapeutic Product Solution and Service
Table 22. Date of Enter into RNAi for Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global RNAi for Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global RNAi for Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global RNAi for Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global RNAi for Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global RNAi for Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global RNAi for Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global RNAi for Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America RNAi for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America RNAi for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America RNAi for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America RNAi for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America RNAi for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe RNAi for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe RNAi for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe RNAi for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe RNAi for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe RNAi for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific RNAi for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific RNAi for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific RNAi for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific RNAi for Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific RNAi for Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America RNAi for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America RNAi for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America RNAi for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America RNAi for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America RNAi for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa RNAi for Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa RNAi for Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa RNAi for Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa RNAi for Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa RNAi for Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa RNAi for Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Alnylam Pharmaceuticals Company Details
Table 63. Alnylam Pharmaceuticals Business Overview
Table 64. Alnylam Pharmaceuticals RNAi for Therapeutic Product
Table 65. Alnylam Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 66. Alnylam Pharmaceuticals Recent Development
Table 67. Arbutus Biopharma (Tekmira) Company Details
Table 68. Arbutus Biopharma (Tekmira) Business Overview
Table 69. Arbutus Biopharma (Tekmira) RNAi for Therapeutic Product
Table 70. Arbutus Biopharma (Tekmira) Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Arbutus Biopharma (Tekmira) Recent Development
Table 72. Arrowhead Company Details
Table 73. Arrowhead Business Overview
Table 74. Arrowhead RNAi for Therapeutic Product
Table 75. Arrowhead Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Arrowhead Recent Development
Table 77. Dicerna Pharmaceuticals Company Details
Table 78. Dicerna Pharmaceuticals Business Overview
Table 79. Dicerna Pharmaceuticals RNAi for Therapeutic Product
Table 80. Dicerna Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Dicerna Pharmaceuticals Recent Development
Table 82. Mirna Therapeutics Company Details
Table 83. Mirna Therapeutics Business Overview
Table 84. Mirna Therapeutics RNAi for Therapeutic Product
Table 85. Mirna Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Mirna Therapeutics Recent Development
Table 87. Quark Pharmaceuticals Company Details
Table 88. Quark Pharmaceuticals Business Overview
Table 89. Quark Pharmaceuticals RNAi for Therapeutic Product
Table 90. Quark Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Quark Pharmaceuticals Recent Development
Table 92. RXi Pharmaceuticals Company Details
Table 93. RXi Pharmaceuticals Business Overview
Table 94. RXi Pharmaceuticals RNAi for Therapeutic Product
Table 95. RXi Pharmaceuticals Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 96. RXi Pharmaceuticals Recent Development
Table 97. Silence Therapeutics Company Details
Table 98. Silence Therapeutics Business Overview
Table 99. Silence Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Silence Therapeutics Recent Development
Table 101. Benitec Biopharma Company Details
Table 102. Benitec Biopharma Business Overview
Table 103. Benitec Biopharma RNAi for Therapeutic Product
Table 104. Benitec Biopharma Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Benitec Biopharma Recent Development
Table 106. miRagen Therapeutics Company Details
Table 107. miRagen Therapeutics Business Overview
Table 108. miRagen Therapeutics RNAi for Therapeutic Product
Table 109. miRagen Therapeutics Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 110. miRagen Therapeutics Recent Development
Table 111. Sylentis Company Details
Table 112. Sylentis Business Overview
Table 113. Sylentis RNAi for Therapeutic Product
Table 114. Sylentis Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 115. Sylentis Recent Development
Table 116. Gradalis Company Details
Table 117. Gradalis Business Overview
Table 118. Gradalis RNAi for Therapeutic Product
Table 119. Gradalis Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 120. Gradalis Recent Development
Table 121. Sirnaomics Company Details
Table 122. Sirnaomics Business Overview
Table 123. Sirnaomics RNAi for Therapeutic Product
Table 124. Sirnaomics Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 125. Sirnaomics Recent Development
Table 126. Silenseed Company Details
Table 127. Silenseed Business Overview
Table 128. Silenseed RNAi for Therapeutic Product
Table 129. Silenseed Revenue in RNAi for Therapeutic Business (2016-2021) & (US$ Million)
Table 130. Silenseed Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi for Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. siRNA Features
Figure 3. miRNA Features
Figure 4. shRNA Features
Figure 5. Global RNAi for Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Cancer Case Studies
Figure 7. Cardiovascular Case Studies
Figure 8. HBV Case Studies
Figure 9. Others Case Studies
Figure 10. RNAi for Therapeutic Report Years Considered
Figure 11. Global RNAi for Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global RNAi for Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global RNAi for Therapeutic Market Share by Regions: 2020 VS 2027
Figure 14. Global RNAi for Therapeutic Market Share by Regions (2022-2027)
Figure 15. Global RNAi for Therapeutic Market Share by Players in 2020
Figure 16. Global Top RNAi for Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNAi for Therapeutic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by RNAi for Therapeutic Revenue in 2020
Figure 18. Global RNAi for Therapeutic Revenue Market Share by Type (2016-2021)
Figure 19. Global RNAi for Therapeutic Revenue Market Share by Type (2022-2027)
Figure 20. North America RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America RNAi for Therapeutic Market Share by Type (2016-2027)
Figure 22. North America RNAi for Therapeutic Market Share by Application (2016-2027)
Figure 23. North America RNAi for Therapeutic Market Share by Country (2016-2027)
Figure 24. United States RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe RNAi for Therapeutic Market Share by Type (2016-2027)
Figure 28. Europe RNAi for Therapeutic Market Share by Application (2016-2027)
Figure 29. Europe RNAi for Therapeutic Market Share by Country (2016-2027)
Figure 30. Germany RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific RNAi for Therapeutic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific RNAi for Therapeutic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific RNAi for Therapeutic Market Share by Region (2016-2027)
Figure 40. China RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America RNAi for Therapeutic Market Share by Type (2016-2027)
Figure 48. Latin America RNAi for Therapeutic Market Share by Application (2016-2027)
Figure 49. Latin America RNAi for Therapeutic Market Share by Country (2016-2027)
Figure 50. Mexico RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa RNAi for Therapeutic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa RNAi for Therapeutic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa RNAi for Therapeutic Market Share by Country (2016-2027)
Figure 56. Turkey RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE RNAi for Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 60. Arbutus Biopharma (Tekmira) Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 61. Arrowhead Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 62. Dicerna Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 63. Mirna Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 64. Quark Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 65. RXi Pharmaceuticals Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 66. Silence Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 67. Benitec Biopharma Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 68. miRagen Therapeutics Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 69. Sylentis Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 70. Gradalis Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 71. Sirnaomics Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 72. Silenseed Revenue Growth Rate in RNAi for Therapeutic Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のアンチセンス・RNAi治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Antisense and RNAi Therapeutics Market The global Antisense and RNAi Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界のアンチセンス・RNAi治療市場規模・現状・予測（2021年-2027年） Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (…
- 世界のアンチセンス・RNAi治療市場 2021：企業別、地域別、種類・用途別 The Antisense and RNAi Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の口腔がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Cancer Therapeutic Market The global Oral Cancer Therapeutic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界の乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Therapeutic Market The global Breast Cancer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…